title: Acute pancreatitis during pegylated interferon therapy in a patient with chronic hepatitis B.
authors.forename: Rodolph K
authors.initials: RK
authors.lastname: Vignon
authors.forename: Hassan
authors.initials: H
authors.lastname: Seddik
authors.forename: Fedoua
authors.initials: F
authors.lastname: Rouibaa
authors.forename: Hassane
authors.initials: H
authors.lastname: En-Nouali
authors.forename: Nawal
authors.initials: N
authors.lastname: Kabbaj
authors.forename: Ahmed
authors.initials: A
authors.lastname: Benkirane
mesh_terms: D000208:Acute Disease; D000998:Antiviral Agents / Q000009:adverse effects*; D016903:Drug Monitoring; D042241:Early Diagnosis; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced* / Q000175:diagnosis; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a